AdvisorShares Psychedelics ETF (PSIL): Price and Financial Metrics ETF
PSIL Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $1.24 | 52-week high | $2.25 |
| Prev. close | $1.28 | 52-week low | $1.20 |
| Day low | $1.20 | Volume | 91,700 |
| Day high | $1.28 | Avg. volume | 75,428 |
| 50-day MA | $1.47 | Dividend yield | 0.24% |
| 200-day MA | $1.55 |
PSIL Stock Price Chart Interactive Chart >
AdvisorShares Psychedelics ETF (PSIL) ETF Bio
The Defiance Next Gen Altered Experience ETF (the “Fund”) seeks to track the total return performance, before fees and expenses, of the BITA Medical Psychedelics, Cannabis, and Ketamine Index (the “Index”).
PSIL ETF Info
| Issuer | Advisors Asset Management |
| Expense Ratio | 1% |
| Asset Class | Equity |
| Sector | Alternative ETFs |
| Assets Under Management (AUM) | 7.00M |
| Net Asset Value (NAV) | $1.25 |
| Options? | Yes |
| Total Holdings | 23 |
PSIL Top Holdings
| Symbol | Company | % of Total |
| MNMD | MIND MEDICINE MINDMED INC | 16.24% |
| CYBN | CYBIN INC | 8.95% |
| CMPS | COMPASS PATHWAYS PLC | 6.69% |
| ATAI | ATAI LIFE SCIENCES NV | 6.02% |
| NRXP | NRX PHARMACEUTICALS INC | 5.14% |
| VTGN | VISTAGEN THERAPEUTICS INC | 5% |
| GHRS | GH RESEARCH PLC | 4.52% |
| RLMD | RELMADA THERAPEUTICS INC | 4.3% |
| ALKS | ALKERMES PLC | 4.28% |
| ITCI | INTRA-CELLULAR THERAPIES INC | 4.17% |
PSIL Price Returns
| 1-mo | -14.48% |
| 3-mo | -9.49% |
| 6-mo | -12.06% |
| 1-year | -31.74% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -10.79% |
| 2023 | -25.13% |
| 2022 | -67.24% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
PSIL Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||